Takeabreak2020-08-25 21:55
$万基遗传(MYGN)$ 今年至今跌去30%+的还有$Adma生物制品(ADMA)$, $BioDelivery科学国际(BDSI)$, CRVS查看全文
chuminhua2020-05-23 23:21
5/20,FDA批准了Foundation Medicine和Myriad Genetics$万基遗传(MYGN)$ 的伴随诊断测试,用于AZ和MSD的PARP抑制剂Lynparza(olaparib),用于筛选出适合治疗的转移性去势抵抗性前列腺癌患者。查看全文
网络异常请稍后再试2020-05-12 07:12
$万基遗传(MYGN)$
2019/8/13盘后财报,MISS,8/14号暴跌43%
2019/11/4盘后财报,MISS,11/5号暴跌40%;
2020/2/6盘后财报,MISS,2/7号暴跌30%;
2020/5/5盘后财报,MISS,5/6号跌4%;
这股真是有个性啊。。。。。。查看全文
$万基遗传(MYGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001219036-21-000020 Size: 33 KB 网页链接
$万基遗传(MYGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001274225-21-000004 Size: 7 KB 网页链接
$万基遗传(MYGN)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000899923-21-000063 Act: 34 Size: 8 MB 网页链接
$万基遗传(MYGN)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000899923-21-000055 Act: 34 Size: 647 KB 网页链接
$万基遗传(MYGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001219036-21-000018 Size: 24 KB 网页链接
$万基遗传(MYGN)$ 内部交易: 2021-07-12,Chief Scientific Officer,LANCHBURY JERRY S ,卖出,50000普通股, $33.55
$万基遗传(MYGN)$ 内部交易: 2021-07-13,Chief Scientific Officer,LANCHBURY JERRY S ,卖出,43295普通股, $33.74
$万基遗传(MYGN)$ 内部交易: 2021-07-13,Chief Scientific Officer,LANCHBURY JERRY S ,期权,43295普通股, $26.49
$万基遗传(MYGN)$ 内部交易: 2021-07-12,Chief Scientific Officer,LANCHBURY JERRY S ,期权,50000普通股, $26.49
$万基遗传(MYGN)$ 内部交易: 2021-07-09,Chief Scientific Officer,LANCHBURY JERRY S ,卖出,50000普通股, $32.62